Early impact of methadone induction for heroin dependence: Differential effects of two dose sequences in a randomized controlled study

Experimental and Clinical Psychopharmacology

Volumn 14, Issue 1, 2006, Pages 52-67

  Greenwald, Mark K ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Craving; Dependence; Heroin; Methadone induction; Mood; Plasma level; Withdrawal

Indexed keywords

DIAMORPHINE; METHADONE;

ADULT; AROUSAL; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG RETENTION; DRUG SAFETY; DRUG SPECIFICITY; DRUG USE; FEMALE; GENDER; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; NAUSEA; OUTPATIENT; PATIENT CARE; PNEUMONIA; PRURITUS; RACE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; VOMITING; WITHDRAWAL SYNDROME;

ADULT; AFFECT; FEMALE; HEROIN DEPENDENCE; HUMANS; LOGISTIC MODELS; MALE; METHADONE; MIDDLE AGED; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 33644591738     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.14.1.52     Document Type: Article

References (53)

1. Alburges, M. E., Huang, W., Foltz, R. L., & Moody, D. E. (1996). Determination of methadone and its N-demethylation metabolites in biological specimens by GC-PICI-MS. Journal of Analytical Toxicology, 20, 362-368.
2. Alterman, A. I., Kampman, K., Boardman, C. R., Cacciola, J. S., Rutherford, M. J., McKay, J. R., & Maany, I. (1997). A cocaine-positive baseline urine predicts outpatient treatment attrition and failure to attain initial abstinence. Drug and Alcohol Dependence, 46, 79-85.
3. Caplehorn, J. R. M., & Drummer, O. H. (1999). Mortality associated with New South Wales methadone programs in 1994: Lives lost and saved. Medical Journal of Australia, 170, 104-109.
4. Carpenter, M. J., Chutuape, M. A., & Stitzer, M. L. (1998). Heroin snorters versus injectors: Comparison on drug use and treatment outcome in age-matched samples. Drug and Alcohol Dependence, 53, 11-15.
5. Carrieri, M. P., Rey, D., Loundou, A., Lepeu, G., Sobel, A., Obadia, Y., & the MANIF-2000 Study Group. (2003). Evaluation of buprenorphine maintenance treatment in a French cohort of HIV-infected injecting drug users. Drug and Alcohol Dependence, 72, 13-21.
6. Carroll, K. M., Nich, C., Ball, S. A., McCance, E., Frankfurter, T. L., & Rounsaville, B. J. (2000). One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: Sustained effects of treatment. Addiction, 95, 1335-1349.
7. Carroll, K. M., Rounsaville, B. J., Nich, C., Gordon, L. T., Wirtz, P. W., & Gawin, F. (1994). One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence: Delayed emergence of psychotherapy effects. Archives of General Psychiatry, 51, 989-997.
8. Chait, L. D., Uhlenhuth, E. H., & Johanson, C. E. (1985). The discriminative stimulus and subjective effects of d-amphetamine in humans. Psychopharmacology, 86, 307-312.
9. Chui, P. T., & Gin, T. (1992). A double-blind randomised trial comparing postoperative analgesia after perioperative loading doses of methadone or morphine. Anaestheisa and Intensive Care, 20, 46-51.
10. Dawe, S., & Gray, J. A. (1995). Craving and drug reward: A comparison of methadone and clonidine in detoxifying opiate addicts. Drug and Alcohol Dependence, 39, 207-212.
11. DeMaria, P. A., Jr., Sterling, R., & Weinstein, S. P. (2000). The effect of stimulant and sedative use on treatment outcome of patients admitted to methadone maintenance treatment. American Journal on Addictions, 9, 145-153.
12. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1996). Structured Clinical Interview for DSM-IV axis disorders - Patient edition (SCID-I/P, Version 2.0). New York: New York State Psychiatric Institute, Biometrics Research Department.
13. Greenwald, M. K. (2002). Heroin craving and drug use in opioid-maintained volunteers: Effects of methadone dose variations. Experimental and Clinical Psychopharmacology, 10, 39-46.
14. Greenwald, M. K. (2005). Opioid craving and seeking behavior in physically dependent volunteers: Effects of acute withdrawal and drug reinforcement opportunity. Experimental and Clinical Psychopharmacology, 13, 3-14.
15. Greenwald, M. K., Johanson, C. E., Bueller, J. A., Chang, Y., Moody, D. E., Kilbourn, M. R., et al. (2005). Buprenorphine duration of action: mu-opioid receptor availability, pharmacokinetic and behavioral indices. Manuscript submitted for publication.
16. Greenwald, M. K., Johanson, C. E., Moody, D. E., Woods, J. H., Kilbourn, M. R., Koeppe, R. A., et al. (2003). Effects of buprenorphine maintenance dose on mu-opioid receptor binding potential, plasma concentration, and antagonist blockade in heroin-dependent volunteers. Neuropsychopharmacology, 28, 2000-2009.
17. Greenwald, M. K., Johanson, C. E., & Schuster, C. R. (1999). Opioid reinforcement in heroin-dependent volunteers during buprenorphine maintenance. Drug and Alcohol Dependence, 56, 191-203.
18. Greenwald, M. K., & Roehrs, T. A. (2005). Mu-opioid self-administration versus passive administration in heroin abusers produces differential EEG activation. Neuropsychopharmacology, 30, 212-221.
19. Greenwald, M. K., Schuh, K. J., Hopper, J. A., Schuster, C. R., & Johanson, C. E. (2002). Effects of buprenorphine sublingual tablet maintenance on opioid drug-seeking behavior by humans. Psychopharmacology, 160, 344-352.
20. Greenwald, M. K., Schuh, K. J., & Stine, S. M. (2003). Transferring heroin-dependent outpatients stabilized on moderate-dose methadone to the buprenorphine sublingual tablet: A preliminary study. American Journal on Addictions, 12, 365-374.
21. Health Canada. (2001). Methadone maintenance guidelines. Toronto, Ontario, Canada: College of Physicians of Ontario. Retrieved June 2004 from www.cpso.on.ca
22. Higgins, S. T., Badger, G. J., & Budney, A. J. (2000). Initial abstinence and success in achieving longer term cocaine abstinence. Experimental and Clinical Psychopharmacology, 8, 377-386.
23. Higgins, S. T., Budney, A. J., Bickel, W. K., Foerg, F. E., Donham, R., & Badger, G. J. (1994). Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Archives of General Psychiatry, 54, 568-576.
24. Hubbard, R. L., Marsden, M. E., Rachal, J. V., Harwood, H. J., & Ginzburg, H. M. (1989). Drug abuse treatment: A national study of effectiveness. Chapel Hill: University of North Carolina Press.
25. Humeniuk, R., Ali, R., White, J., Hall, W., & Farrell, M. (2000). Proceedings of expert workshop on the induction and stabilisation of patients onto methadone (Monograph Series No. 39). Adelaide, South Australia: Commonwealth Department of Health and Aged Care. Retrieved June 2004 from www.health .gov.au
26. Iguchi, M. Y., & Stitzer, M. L. (1991). Predictors of opiate drug abuse during a 90-day methadone detoxification. American Journal of Drug and Alcohol Abuse, 17, 279-294.
27. Inturrisi, C. E., & Verebely, K. (1972). The levels of methadone in the plasma in methadone maintenance. Clinical Pharmacology and Therapeutics, 13, 633-637.
28. Jones, H. E., Strain, E. C., Bigelow, G. E., Walsh, S. L., Stitzer, M. L., Eissenberg, T., & Johnson, R. E. (1998). Induction with levomethadyl acetate: Safety and efficacy. Archives of General Psychiatry, 55, 729-736.
29. Judson, B. A., & Goldstein, A. (1979). Levo-alpha-acetylmethadol (LAAM) in the treatment of heroin addicts: I. Dosage schedule for induction and stabilization. Drug and Alcohol Dependence, 4, 461-466.
30. Karch, S. B., & Stephens, B. G. (2000). Toxicology and the pathology of deaths related to methadone: Retrospective review. Western Journal of Medicine, 172, 11-14.
31. Kreek, M. J. (1992). Rationale for maintenance pharmacotherapy of opioid dependence. In C. P. O'Brien & J. H. Jaffe (Eds.), Addictive states (pp. 205-230). New York: Raven Press.
32. Loimer, N., & Schmid, R. (1992). The use of plasma levels to optimize methadone maintenance treatment. Drug and Alcohol Dependence, 30, 241-246.
33. McLellan, A. T., Alterman, A. I., Metzger, D. S., Grissom, G. R., Woody, G. E., Luborsky, L., & O'Brien, C. P. (1994). Similarity of outcome predictors across opiate, cocaine, and alcohol treatments: Role of treatment services. Journal of Consulting and Clinical Psychology, 62, 1141-1158.
34. McLellan, A. T., Luborsky, L., Woody, G., O'Brien, C. P., & Druley, K. A. (1983). Predicting response to alcohol and drug abuse treatments: Role of psychiatric severity. Archives of General Psychiatry, 40, 620-625.
35. McNair, D. M., Lorr, M., & Droppleman, L. F. (1971). Manual for the Profile of Mood States. San Diego, CA: EdITS.
36. Morral, A. R., Belding, M. A., & Iguchi, M. Y. (1999). Identifying methadone maintenance clients at risk for poor treatment response: Pretreatment and early progress. Drug and Alcohol Dependence, 55, 25-33.
37. Morral, A. R., Iguchi, M. Y., Belding, M. A., & Lamb, R. J. (1997). Natural classes of treatment response. Journal of Consulting and Clinical Psychology, 65, 673-685.
38. Payte, J. T., Zweben, J. E., & Martin, J. (2003). Opioid maintenance treatment. In A. W. Graham, T. K. Schultz, M. F. Mayo-Smith, R. K. Ries, & B. B. Wilford (Eds.), Principles of addiction medicine (pp. 751-766). Chevy Chase, MD: American Society of Addiction Medicine.
39. Preston, K. L., Silvemian, K., Higgins, S. T., Brooner, R. K., Montoya, I., Schuster, C. R., & Cone, E. J. (1998). Cocaine use early in treatment predicts outcome in a behavioral treatment program. Journal of Consulting and Clinical Psychology, 66, 691-696.
40. Roll, J. M., Chermack, S. T., & Chudzynski, J. E. (2004). Investigating the use of contingency management in the treatment of cocaine abuse among individuals with schizophrenia: A feasibility study. Psychiatry Research, 125, 61-64.
41. Saxon, A., Fleming, C., Jackson, T. R., Wells, E., & Calsyn, D. A. (1994). Predictors of methadone treatment outcome. NIDA Research Monograph, 153, 143.
42. Schuster, C. R., Greenwald, M. K., Johanson, C. E., & Heishman, S. J. (1995). Measurement of drug craving during naloxone-precipitated withdrawal in methadone-maintained volunteers. Experimental and Clinical Psychopharmacology, 3, 424-431.
43. Silverman, K., Wong, C. J., Higgins, S. T., Brooner, R. K., Montoya, I. D., Contoreggi, C., et al. (1996). Increasing opiate abstinence through voucher-based reinforcement therapy. Drug and Alcohol Dependence, 41, 157-165.
44. Sofuoglu, M., Gonzalez, G., Poling, J., & Kosten, T. R. (2003). Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence. American Journal of Drug and Alcohol Abuse, 29, 713-727.
45. Stamer, U. M., Grond, S., & Maier, C. (1999). Responders and non-responders to post-operative pain treatment: The loading dose predicts analgesic needs. European Journal of Anaesthesiology, 16, 103-110.
46. Stohler, R., Dursteler-MacFarland, K. M., Gramespacher, C., Petitjean, S., Battegay, R., & Ladewig, D. (2000). A comparison of heroin chasers with heroin injectors in Switzerland. European Addiction Research, 6, 154-159.
47. Swift, R. M., & Stout, R. L. (1992). The relationship between craving, anxiety, and other symptoms in opioid withdrawal. Journal of Substance Abuse, 4, 19-26.
48. Tiffany, S. T., Fields, L., Singleton, E., Haertzen, C., & Henningfield, J. E. (1995). [The development of a heroin craving questionnaire]. Unpublished raw data.
49. van Beusekom, I., & Iguchi, M. Y. (2001). A review of recent advances in knowledge about methadone maintenance treatment. Cambridge, England: RAND Europe. Retrieved June 2004 from http://www.rand.org/publications/MR/MR1396/ index.html
50. Verebely, K., Volavka, J., Mule, S., & Resnick, R. (1975). Methadone in man: Pharmacokinetic and excretion studies in acute and chronic treatment. Clinical Pharmacology and Therapeutics, 18, 180-190.
51. Verster, A., & Buning, E. (2000). Methadone guidelines. Amsterdam: Euro-Methwork. Retrieved March 2003 from http:// www.q4q.nl/methwork/
52. Wagner-Servais, D., & Erkens, M. (2003). Methadone-related deaths associated with faulty induction procedures. Journal of Maintenance in the Addictions, 2, 57-67.
53. Zachary, R. A. (1991). Shipley Institute of Living Scale: Revised manual. Los Angeles: Western Psychological Services.